{"id":416,"date":"2023-12-11T12:11:42","date_gmt":"2023-12-11T16:11:42","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=416"},"modified":"2023-12-11T12:11:42","modified_gmt":"2023-12-11T16:11:42","slug":"bayh-dole-act-march-in-rights-part-of-white-house-plan-to-lower-drug-prices","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/12\/11\/bayh-dole-act-march-in-rights-part-of-white-house-plan-to-lower-drug-prices\/","title":{"rendered":"Bayh-Dole Act March-In Rights Part of White House Plan to Lower Drug Prices"},"content":{"rendered":"<p>Following enactment of the Inflation Reduction Act, which provides for Medicare drug price negotiations, the White House has\u00a0<a href=\"https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2023\/12\/07\/fact-sheet-biden-harris-administration-announces-new-actions-to-lower-health-care-and-prescription-drug-costs-by-promoting-competition\/\" target=\"_blank\" rel=\"noopener\">announced<\/a>\u00a0new actions to lower drug costs, including the release of a proposed framework for agencies to exercise march-in rights under the Bayh-Dole Act to promote public accessibility to tax-payer-funded drugs. If adopted, the framework would make it easier for the government to exercise march-in rights and would impact the value of license rights to government-funded inventions.<\/p>\n<p>Read the full\u00a0<em>Alert <\/em>on the <a href=\"https:\/\/www.duanemorris.com\/alerts\/white_house_announces_framework_use_march_in_rights_under_bayh_dole_act_lower_drug_prices_1223.html\">Duane Morris LLP website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Following enactment of the Inflation Reduction Act, which provides for Medicare drug price negotiations, the White House has\u00a0announced\u00a0new actions to lower drug costs, including the release of a proposed framework for agencies to exercise march-in rights under the Bayh-Dole Act to promote public accessibility to tax-payer-funded drugs. If adopted, the framework would make it easier &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/12\/11\/bayh-dole-act-march-in-rights-part-of-white-house-plan-to-lower-drug-prices\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bayh-Dole Act March-In Rights Part of White House Plan to Lower Drug Prices&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[681,381,509,682,224,143],"ppma_author":[521],"class_list":["post-416","post","type-post","status-publish","format-standard","hentry","category-general","tag-bayh-dole-act","tag-drug-prices","tag-drug-pricing","tag-march-in-rights","tag-ryan-smith","tag-vicki-norton"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=416"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/416\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=416"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}